ThyssenKrupp Nucera stock (DE000NCA0001): Hydrogen specialist under pressure after guidance cut

ThyssenKrupp Nucera recently cut its guidance for the current 2024/25 financial year, citing project delays and a slower ramp?up in large?scale green hydrogen projects, according to a company statement published in May 2025 on its investor relations website (ThyssenKrupp Nucera IR as of 05/2025). The company now expects lower sales growth and a weaker earnings contribution from its alkaline water electrolysis segment, which weighed on the share price in recent trading sessions, as reported by a German financial news service in late May 2025 (Börsen-Zeitung as of 05/2025).

As of: 08.06.2026

By the editorial team – specialized in equity coverage.

ThyssenKrupp Nucera: core business model

ThyssenKrupp Nucera is a specialist in electrolysis technology, emerging from the former electrolytic technologies division of Thyssenkrupp. The company focuses on large?scale systems that use electricity to split water into hydrogen and oxygen, targeting industrial customers in chemicals, steel and energy. Its roots in chlor?alkali electrolysis provide a long operating history and reference base in corrosive industrial environments, according to company information from its 2023/24 annual report, published in December 2024 (ThyssenKrupp Nucera Annual Report 2023/24 as of 12/2024).

The business model combines engineering expertise, project management and service contracts. ThyssenKrupp Nucera designs, builds and sometimes operates electrolysis plants for customers worldwide, often as part of large industrial decarbonization projects. Revenue is generated mainly from long?term equipment contracts and related services rather than from commodity hydrogen sales. This positions the company as a technology supplier rather than a pure hydrogen producer, in line with its strategy outlined at the time of its Frankfurt IPO in July 2023 (Deutsche Börse listing information as of 07/2023).

A key feature of the model is the focus on alkaline water electrolysis, which is considered a relatively mature and cost?efficient technology for large hydrogen volumes. The company leverages standardised modules that can be combined into gigawatt?scale plants, aiming to benefit from economies of scale. At the same time, it continues to generate revenue from its established chlor?alkali business, which provides a more stable earnings base compared to the emerging green hydrogen segment, as pointed out in a sector review by a European investment bank in October 2024 (European investment bank hydrogen report as of 10/2024).

Main revenue and product drivers for ThyssenKrupp Nucera

The main revenue driver for ThyssenKrupp Nucera is its alkaline water electrolysis (AWE) product line. These systems are designed for large?scale hydrogen production, particularly for ammonia, methanol and synthetic fuel projects as well as low?carbon steel. The company reported a significant increase in order intake for green hydrogen projects in its 2023/24 financial report, but also acknowledged that revenue recognition may lag due to complex project timelines (ThyssenKrupp Nucera Annual Report 2023/24 as of 12/2024).

Alongside AWE, the established chlor?alkali business continues to contribute a substantial portion of sales. This unit supplies electrolysis technology for the production of chlorine and caustic soda, a segment with more predictable demand patterns tied to the chemical industry. According to the 2023/24 report, chlor?alkali projects generated recurring service and spare parts revenue, which partially offsets the volatility in new hydrogen orders (ThyssenKrupp Nucera Annual Report 2023/24 as of 12/2024).

Regionally, Europe and the Middle East have been key markets so far, with growing project activity in North America following the introduction of supportive hydrogen incentives under the US Inflation Reduction Act. Management highlighted the strategic importance of the US market for future growth and project pipeline visibility during a capital markets presentation in November 2024 (ThyssenKrupp Nucera Capital Markets Day as of 11/2024). For US?based investors, this exposure to US hydrogen subsidies and industrial decarbonization projects is a central aspect of the investment case.

Conclusion

The recent guidance cut underlines how dependent ThyssenKrupp Nucera still is on the timing of large hydrogen projects and political support schemes. While its technology portfolio and installed base in electrolysis offer structural growth opportunities, short?term earnings visibility remains limited and project delays can quickly affect sentiment. For US investors, the stock represents targeted exposure to the global and US green hydrogen build?out, but also to the execution and policy risks inherent in this emerging sector.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.